CAS 303-38-8|2,3-Dihydroxybenzoic acid
| Common Name | 2,3-Dihydroxybenzoic acid | ||
|---|---|---|---|
| CAS Number | 303-38-8 | Molecular Weight | 154.120 |
| Density | 1.6±0.1 g/cm3 | Boiling Point | 362.5±32.0 °C at 760 mmHg |
| Molecular Formula | C7H6O4 | Melting Point | 204-206 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 187.2±21.6 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 2,3-dihydroxybenzoic acid |
|---|---|
| Synonym | More Synonyms |
2,3-Dihydroxybenzoic acid BiologicalActivity
| Description | Pyrocatechuic acid is a normal human benzoic acid metabolite found in plasma, and has increased levels after aspirin ingestion. |
|---|---|
| Related Catalog | Research Areas >>Others |
| Target | Human Endogenous Metabolite |
| In Vitro | Pyrocatechuic acid (2,3-Dihydroxybenzoic acid) is a normal human benzoic acid metabolite found in plasma, and has increased levels after aspirin ingestion[1]. |
| References | [1]. Grootveld M, et al. 2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism. Biochem Pharmacol. 1988 Jan 15;37(2):271-80. |
Chemical & Physical Properties
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 362.5±32.0 °C at 760 mmHg |
| Melting Point | 204-206 °C(lit.) |
| Molecular Formula | C7H6O4 |
| Molecular Weight | 154.120 |
| Flash Point | 187.2±21.6 °C |
| Exact Mass | 154.026611 |
| PSA | 77.76000 |
| LogP | 1.80 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.671 |
| InChIKey | GLDQAMYCGOIJDV-UHFFFAOYSA-N |
| SMILES | O=C(O)c1cccc(O)c1O |
| Storage condition | 2-8°C |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- >3 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 196,478,1976
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36-S37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | DG8576490 |
| HS Code | 2918290000 |
Customs
| HS Code | 2918290000 |
|---|---|
| Summary | HS: 2918290000 other carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) VAT:17.0% MFN tariff:6.5% General tariff:30.0% |
Articles72
More Articles| Molecular insights into shellac film coats from different aqueous shellac salt solutions and effect on disintegration of enteric-coated soft gelatin capsules. Int. J. Pharm. 484(1-2) , 283-91, (2015) The purpose of this investigation was to study the effect of using different salts of shellac on the disintegration properties of shellac-based enteric coatings. In the last two decades, shellac has b... | |
| Identifying chelators for metalloprotein inhibitors using a fragment-based approach. J. Med. Chem. 54 , 591-602, (2011) Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors. When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compounds produced... | |
| N-glycosylation profile analysis of Trastuzumab biosimilar candidates by Normal Phase Liquid Chromatography and MALDI-TOF MS approaches. J. Proteomics 127 , 225-33, (2015) The pharmaceutical market has entered an era in which the production of new therapeutics is being often replaced by "biosimilars", copies of already commercialized products waiting for the patents to ... |
Synonyms
| catecholcarboxylicacid |
| 2,3-DIAMIDOXIMO-1,4-DIHYDROXYNAPHTHALENE |
| Catechol-3-carboxylic Acid |
| 2,3-dihydroxybenzoate |
| EINECS 206-139-5 |
| O-PYROCATECHUIC ACID |
| di-hydroxybenzoic acid |
| 2-pyrocatechuicacid |
| pyrocatechuic acid |
| Benzoic acid, 2,3-dihydroxy- |
| Pyrocatechol-3-carboxylic Acid |
| 2,3-Dihydroxybenzoic acid |
| RARECHEM AL BE 0035 |
| 2,3-Dihydroxybenzoic |
| dihydroxybenzoic acid |
| UNII-70D5FBB392 |
| DOBK |
| MFCD00002446 |
| 2,3 DHB |
| 2,3-Dihydroxybenzoicacid |
| hydroxysalicylic acid |
| 2,3–Dihydroxybenzoic acid |
